PTC THERAPEUTICS, INC. Insider Trading for January 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PTC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PTC THERAPEUTICS, INC. for January 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | M | 10.85 | 3,125 | 33,906 | 75,318 | |
| Jan 17 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Buy | M | 10.85 | 3,125 | 33,906 | 25,648 | 22.5 K to 25.6 K (+13.87 %) |
| Jan 09 2017 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 06 2017 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Sell | S | 11.82 | 78 | 922 | 2,687 | 2.8 K to 2.7 K (-2.82 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Option Exercise | A | 11.23 | 35,000 | 393,050 | 35,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Grant | A | 0.00 | 720 | 0 | 2,765 | 2 K to 2.8 K (+35.21 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | EVP Research Pharma ... | Grant | A | 0.00 | 6,000 | 0 | 16,000 | 10 K to 16 K (+60.00 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Option Exercise | A | 11.23 | 24,000 | 269,520 | 24,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Renaud Ronald C JR | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Koppel Adam | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | McDonough Cameron Geoffrey | Director | Option Exercise | A | 11.23 | 12,000 | 134,760 | 12,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Ong Tuyen | Chief Medical Offic ... | Option Exercise | A | 11.23 | 35,000 | 393,050 | 35,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Ong Tuyen | Chief Medical Offic ... | Grant | A | 0.00 | 6,000 | 0 | 6,000 | 0 to 6 K |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 11.23 | 126,000 | 1,414,980 | 126,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Grant | A | 0.00 | 21,600 | 0 | 28,876 | 7.3 K to 28.9 K (+296.87 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Option Exercise | A | 11.23 | 56,000 | 628,880 | 56,000 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Rothera Mark | Chief Commercial Of ... | Grant | A | 0.00 | 9,600 | 0 | 22,523 | 12.9 K to 22.5 K (+74.29 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Option Exercise | A | 11.23 | 52,500 | 589,575 | 52,500 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Kovacs Shane William Charles | Chief Financial Off ... | Grant | A | 0.00 | 9,000 | 0 | 27,850 | 18.9 K to 27.9 K (+47.75 %) |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | A | 11.23 | 52,500 | 589,575 | 52,500 | |
| Jan 05 2017 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Grant | A | 0.00 | 9,000 | 0 | 27,034 | 18 K to 27 K (+49.91 %) |